Morningstar - Barclays PLC (BARC) Barclays Reports 2018 Results; Non-U.K. Business Shows Positive Development

Report

Morningstar

Derya Guzel

EUR 100.00 For Business Accounts Only

Barclays Reports 2018 Results; Non-U.K. Business Shows Positive Development

Barclays reported profits before tax of GBP 3.5 billion for full-year 2018, unchanged from last year. Results were again held back by litigation and conduct charges totaling GBP 2.2 billion, slightly up from 2017 as a result of the GBP 1.4 billion settlement regarding the residential mortgage-backed securities case in the U.S. and GBP 0.4 billion in payment protection insurance charges. Adjusted for this, profits before tax increased 20% to GBP 5.7 billion as higher net trading income more than ...

22/02/2019 13 EN

Underlying

Barclays PLC

Barclays is a holding company. Through its subsidiaries, Co. is a financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management and investment management services. Co.'s business segments are: Barclays U.K, which provides everyday products and services to retail customers and small to medium sized enterprises; Barclays International, which delivers products and services designed for Co.'s corporate, wholesale and international banking clients; and Head Office, which comprises head office and central support functions (including treasury) and businesses in transition.

See profile

GB0031348658 London Stock Exchange United Kingdom

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Derya Guzel

Other Reports on these Companies

SmartInsider

Barclays: 1 director

A director at Barclays sold 18,920 shares at 372p and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board members al...

Free Trial

August 20, 2025 August 20, 2025 1 EN

BusinessWire

Barclays Appoints Kieran Whitty as a Co-Head of Healthcare for Europe, Middle East and Africa

LONDON--(BUSINESS WIRE)-- Barclays today announces the appointment of Kieran Whitty as Co-Head of Healthcare EMEA (Europe, Middle East and Africa), working alongside Sid Chhibbar, Co-Head of Healthcare EMEA. This appointment reflects Barclays’ effort to continue its growth in the UK and Continental Europe, which is a key focus for Barclays investment bank. Kieran joins Barclays from Bank of America where he spent 18 years, most recently as a Managing Director in the EMEA Healthcare team. He has a strong track record advising clients, with extensive experience and connections across the healt...

March 20, 2025 March 20, 2025 1 EN

BusinessWire

Barclays Bank PLC Announces Proposed Change to Index Underlying the iPath® Select MLP ETNs

NEW YORK--(BUSINESS WIRE)-- Barclays Bank PLC (“Barclays”), as index sponsor for the CIBC Atlas Select Index (the “Index”), announced that it is running a consultation process on proposed changes to the Index. The return on the iPath® Select MLP ETNs (the “ETNs”), which are issued by Barclays Bank PLC, is linked to the performance of the Index. Currently, as described in the prospectus relating to the ETNs, the Index rebalances on a quarterly basis over four index business days. The proposed change would increase the number of days over which each quarterly rebalancing occurs to eight busine...

February 28, 2025 February 28, 2025 1 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Barclays Reports 2018 Results; Non-U.K. Business Shows Positive Development

Barclays: 1 director

Barclays Appoints Kieran Whitty as a Co-Head of Healthcare for Europe, Middle East and Africa

Barclays Bank PLC Announces Proposed Change to Index Underlying the iPath® Select MLP ETNs

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe